4Hung S I,Chung W H,Jee S H,et al.Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions[J].Pharmacogenet Genomics,2006,16(4):297-306.
5Man C B,Kwan P,Baum L,et al.Association between HLA-B*1502 allele and antiepileptic drug-induced cutaneous reactions in Han Chinese[J].Epilepsia,2007,48(5):1015-1018.
6Hata M,Tanaka Y,Kyoda N,et al.An epoxidation mechanism of earbamazepine by CYP3A4[J].Bioorg Med Chem,2008,16(9):5134-5148.
7Bu H Z,Zhao P,Dalvie D K,et al.Identification of primary and sequential bioactivation pathways of carbamazepine in human liver microsomes using liquid chromatography/tandem mass spectrometry[J].Rapid Commun Mass Spectrom,2007,21(20):3317-3322.
8Lamba J K,Lin Y S,Thummel K,et al.Common allelic variants of cytochrome P4503A4 and their prevalence in different pepulations[J].Pharmacogenetics,2002,12(2):121-132.
9Eiselt R,Domanski T L,Zibat A,et al.Identification and functional characterization of eight CYP3A4 protein variants[J].Pharmacogenetics,2001,11(5):447-558.
10Roujeau J C,Stem R S.Severe Adverse Cutaneous Reactions to Drugs[J].N Engl J Med,1994,331(19):1272-1285.
